My first guest is <a href='https://www.nuffieldhealth.com/consultants/professor-richard-gale'>Professor Richard Gale</a>, Consultant Medical Ophthalmologist, and the Clinical Director at the York Teaching Hospital NHS Foundation Trust, UK. In this episode, we discuss the latest publications and strategies that are employed to support patients in continuing to attend appointments and receive treatment. I have included below the links to the publications that we discuss during this podcast. <a href='https://www.aaojournal.org/article/S0161-6420(20)30748-X/fulltext'>Okada M, et al. Ophthalmology. 2021;128(2):234-47</a><a href='https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2780579'>Okada M, et al. JAMA Ophthalmol. 2021;139(7):769-76</a> Speaker disclosures: Professor Anat Loewenstein Consultancy, Research grants: Allergan, Bayer, Beyeonics Surgical, KHB, Novartis, Notal Vision, Oculis, Oxurion, Pres-By, Roche, Sensor, WebMD, Xbrane    Professor Richard Gale: Consultancy, Research Grants: Alimera, Allergan, Bayer, Novartis, Roche

How to improve your clinic organization to ensure a better patient experience, and optimize adherence to treatment

"A Chat with Anat" is a series for ophthalmologists who are interested in improving delivery of care for patients living with retinal disease, and for those interested in clinically-challenging situations or controversies in care. I’m Professor Anat Loewenstein, Chair of the Department of Ophthalmology at Tel Aviv Sourasky Medical Centre in Israel, and Professor of Ophthalmology and Vice Dean at Tel Aviv University. For each episode, I will be joined by internationally renowned colleagues to discuss these important topics. This podcast series is sponsored and organized by Bayer and produced by ApotheCom.This podcast series is produced and funded by Bayer. The views and opinions expressed throughout this podcast are the speakers' own, based on their clinical experience and expertise. This is not intended for UK audiences.&nbsp;